Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.

Mariatos G, Bothos J, Zacharatos P, Summers MK, Scolnick DM, Kittas C, Halazonetis TD, Gorgoulis VG.

Cancer Res. 2003 Nov 1;63(21):7185-9.

2.

The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains.

Bothos J, Summers MK, Venere M, Scolnick DM, Halazonetis TD.

Oncogene. 2003 Oct 16;22(46):7101-7.

PMID:
14562038
3.

Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate.

Stavridi ES, Huyen Y, Loreto IR, Scolnick DM, Halazonetis TD, Pavletich NP, Jeffrey PD.

Structure. 2002 Jul;10(7):891-9.

4.

Chfr defines a mitotic stress checkpoint that delays entry into metaphase.

Scolnick DM, Halazonetis TD.

Nature. 2000 Jul 27;406(6794):430-5.

PMID:
10935642
5.

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL.

Mol Cell Biol. 1999 Feb;19(2):1202-9.

6.

CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Scolnick DM, Chehab NH, Stavridi ES, Lien MC, Caruso L, Moran E, Berger SL, Halazonetis TD.

Cancer Res. 1997 Sep 1;57(17):3693-6.

7.

Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.

Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD, Berger SL.

Oncogene. 1997 Aug 14;15(7):807-16.

8.

Secosteroid mechanism-based inactivators and site-directed mutagenesis as probes for steroid hormone recognition by 3 alpha-hydroxysteroid dehydrogenase.

Schlegel BP, Pawlowski JE, Hu Y, Scolnick DM, Covey DF, Penning TM.

Biochemistry. 1994 Aug 30;33(34):10367-74.

PMID:
8068673

Supplemental Content

Loading ...
Support Center